§ 13F · FUND PROFILE
Foresite Capital Management VI LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $178M (13F)Positions · 20Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$57M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | CGON | CG Oncology, Inc. | 2.22M | $150M | 32.7% | ±0% |
| 2 | ALMS | ALUMIS INC. | 4.25M | $94M | 20.3% | ±0% |
| 3 | CNTA | Centessa Pharmaceuticals plc | 1.36M | $54M | 11.8% | ±0% |
| 4 | CRVS | Corvus Pharmaceuticals, Inc. | 1.83M | $27M | 5.8% | +33% |
| 5 | DNLI | Denali Therapeutics Inc. | 1.21M | $23M | 5.0% | +21% |
| 6 | AGIO | AGIOS PHARMACEUTICALS, INC. | 525K | $18M | 3.9% | −1% |
| 7 | VSTM | Verastem, Inc. | 3.15M | $17M | 3.6% | ±0% |
| 8 | KYMR | Kymera Therapeutics, Inc. | 146K | $12M | 2.6% | ±0% |
| 9 | NERV | Minerva Neurosciences, Inc. | 1.99M | $12M | 2.6% | NEW |
| 10 | CLDX | Celldex Therapeutics, Inc. | 316K | $10M | 2.2% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE FORESITE SIGNAL
AC read
Foresite Capital Management VI LLC is a Other fund managing $178 million in assets. The fund runs a focused portfolio of just 20 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q2 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed